Associating somatic mutations to clinical outcomes: a pan-cancer study of survival time.

Genome Med · 2019 · PMC6540540 · PMID 31138328

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

did not find mutation burden to be informative for prognosis, we found it is significantly associated with survival time (or marginally significant) in 7 of the 14 cancer types.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.